Effect of bovine lactoferrin on the MICs of ampicillin/sulbactam (UNASYN), amoxicillin/clavulanic acid (Augmentin), ticarcillin clavulanate (Timentin), and piperacillin-tazobactam (ZOSYN), against clinical and environmental isolates of motile Aeromonas.
WaKabongo
Masau
M
Osteopathic Medical Center, Des Moines University, Des Moines, IA 50312, USA.
Stucki
Zachary N
ZN
Torbert
Deborah Potym
DP
Olweny
Justine
J
D000333:Aeromonas / Q000187:drug effects*; D019980:Amoxicillin-Potassium Clavulanate Combination / Q000494:pharmacology*; D000667:Ampicillin / Q000494:pharmacology*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002417:Cattle; D002969:Clavulanic Acids / Q000494:pharmacology*; D007781:Lactoferrin / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000494:pharmacology*; D010878:Piperacillin / Q000494:pharmacology*; D000077725:Piperacillin, Tazobactam Drug Combination; D013407:Sulbactam / Q000494:pharmacology*; D013982:Ticarcillin / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D002969:Clavulanic Acids; D000077725:Piperacillin, Tazobactam Drug Combination; C035444:sultamicillin; D019980:Amoxicillin-Potassium Clavulanate Combination; D000667:Ampicillin; C043215:ticarcillin-clavulanic acid; D010397:Penicillanic Acid; D007781:Lactoferrin; D013982:Ticarcillin; D013407:Sulbactam; D010878:Piperacillin